Transitional Year·Las Vegas, NV

HCA Healthcare Sunrise Health GME/Southern Hills

Signal lift13%49%+36 pp with a signal here
Allocate signal →Track an away here25-26 cycle · applicant-level
Step 2 invited
240–265
p10 – p90
Sample N
464
applicants this cycle
This cycle
-
no tracked aways yet
Match rate
2.8%
13 of 464 applicants
01Cohort funnelthis cycle
N = 464
Applied
464
100.0%
Invited
83
17.9%
Class size
13
2.8%
No visa sponsorshipGraduated within 2 yearsPreliminary
Your fitHCA Healthcare Sunrise Health GME/Southern Hills Program

Create a free profile to see your personalized fit

Get started
Applicant profile2025 data

What successful applicants at this program look like.

See how competitive you are here

Compare your stats against applicants at HCA Healthcare Sunrise Health GME

Create free account

Who to contact

Training sites3 hospitals · Las Vegas
  • 1
    Southern Hills Hospital & Medical Center
    Las Vegas, NV
    Primary
  • 2
    HCA Healthcare Sunrise Health GME
    Henderson, NV
    Sponsor
  • 3
    MountainView Hospital
    Las Vegas, NV
    Participant
Interview invites
Loading...
Score rangesinvited cohort
USMLE Step 2 CK240 – 265
180205230255280
COMLEX Level 2 CE514 – 750
400500600700800
Interview rates
US MD
20%
US DO
22%
US IMG
5%
Non-US IMG
0%
Applicant origin
In-state
46%
Out-of-state
15%
Interview prepTransitional Year
personalTell me about yourself.★ common
specialtyWhy did you choose this specialty?★ common
programWhy are you interested in our program?★ common
behavioralWhat are your strengths and weaknesses?★ common
personalWhere do you see yourself in 5-10 years?★ common
Save this program

Add HCA Healthcare Sunrise Health GME/Southern Hills to your list

Build a personal match list. Compare programs side-by-side, see how your timing stacks against peers, and get notified when peers hear back.

Next

Calculate your match probability for Transitional Year.

See how your profile compares across all programs.

Open calculator →

Program data, 2025 release. Not medical advice. © 2026 Rezumab LLC.